SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-069747
Filing Date
2023-12-12
Accepted
2023-12-12 16:35:59
Documents
13
Period of Report
2023-12-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20231206.htm   iXBRL 8-K 46215
2 EX-3.1 crnx-ex3_1.htm EX-3.1 279107
  Complete submission text file 0000950170-23-069747.txt   483426

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20231206.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20231206_lab.xml EX-101.LAB 13343
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20231206_pre.xml EX-101.PRE 9842
7 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20231206_htm.xml XML 4730
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 231481674
SIC: 2834 Pharmaceutical Preparations